(6S,9AS)-N-BENZYL-6-(4-HYDROXYBENZYL)-4,7-DIOXO-2-((3-(PYRIDIN-2-YL)ISOXAZOL-5-YL)METHYL)-8-(QUINOLIN-5-YLMETHYL)HEXAHYDRO-2H-PYRAZINO(2,1-C)(1,2,4)TRIAZINE-1(6H)-CARBOXAMIDE
UNII S8F6TWL476
Substance Identification & Data
This profile provides standardized clinical and technical data for (6s,9as)-n-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2h-pyrazino(2,1-c)(1,2,4)triazine-1(6h)-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S8F6TWL476.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2710292-55-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C40H36N8O5 RXZGEZOZWDKTQS-BCRBLDSWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (6s,9as)-n-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2h-pyrazino(2,1-c)(1,2,4)triazine-1(6h)-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.